[1]侯华芳,夏艳秋,张 哲,等.消化道肿瘤标记物CEA和CA-199比值对结直肠癌预后的影响[J].医学信息,2025,38(08):70-74.[doi:10.3969/j.issn.1006-1959.2025.08.014]
　HOU Huafang,XIA Yanqiu,ZHANG Zhe,et al.Effect of CEA and CA-199 Ratio as Gastrointestinal Tumor Markers on the Prognosis of Colorectal Cancer[J].Journal of Medical Information,2025,38(08):70-74.[doi:10.3969/j.issn.1006-1959.2025.08.014]
点击复制

消化道肿瘤标记物CEA和CA-199比值对结直肠癌预后的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年08期
页码:
70-74
栏目:
论著
出版日期:
2025-04-15

文章信息/Info

Title:
Effect of CEA and CA-199 Ratio as Gastrointestinal Tumor Markers on the Prognosis of Colorectal Cancer
文章编号:
1006-1959（2025）08-0070-05
作者:
侯华芳1; 夏艳秋1; 张 哲2; 雷 枭2
川北医学院附属医院胃肠外二科1，中医科2，四川 南充 637000
Author(s):
HOU Huafang1;  XIA Yanqiu1;  ZHANG Zhe2;  LEI Xiao2
The Second Department of Gastrointestinal Surgery1, Department of Traditional Chinese Medicine2, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan, China
关键词:
结直肠癌; CEA/CA-199; 预后
Keywords:
Colorectal cancer;  CEA/CA-199;  Prognosis
分类号:
R735.3+5
DOI:
10.3969/j.issn.1006-1959.2025.08.014
文献标志码:
A
摘要:
目的 研究CEA及CA-199表达正常的结直肠癌患者的其比值（EAR）对结直肠癌患者预后的影响及预测价值。方法 回顾性分析2014年1月-2016年6月于川北医学院附属医院经外科手术治疗且CEA及CA-199表达正常的129例结直肠癌患者的临床资料，分析其术前外周血EAR水平与结直肠癌临床病例特征的关系及其对预后的影响。结果 ROC曲线下面积（AUC）为0.7588，提示EAR具有诊断意义；ROC曲线截断值为0.5524。EAR的高低与淋巴结转移（P=0.027）及肿瘤大小（P=0.016）有关；生存分析显示，低EAR组总体生存率低于高EAR组（P=0.006）；单因素COX分析结果提示，淋巴结转移（P=0.011）、肿瘤远处转移（P=0.001）及EAR表达情况（P=0.010）是结直肠癌患者的预后影响因素；多因素COX回归分析显示，肿瘤远处转移（P=0.017）及EAR表达情况（P=0.036）是影响结直肠癌患者预后的独立预后因素。结论 术前EAR可以作为CEA及CA-199表达正常的结肠癌患者预后的参考指标。
Abstract:
Objective To study the effect of CEA/ CA-199 (EAR) on the prognosis of colorectal cancer patients with normal CEA and CA-199 expression. Methods The clinical data of 129 colorectal cancer patients with normal CEA and CA-199 expression treated surgically in the Affiliated Hospital of North Sichuan Medical College from January 2014 to June 2016 were analyzed retrospectively. The relationship between preoperative peripheral blood EAR level and clinical case characteristics of colorectal cancer and its impact on prognosis were analyzed. Results The area under the ROC curve (AUC) was 0.7588, suggesting that EAR had diagnostic significance. The cutoff value of ROC curve was 0.5524. The level of EAR was related to lymph node metastasis (P=0.027) and tumor size (P=0.016). Survival analysis showed that the overall survival rate of the low EAR group was lower than that of the high EAR group (P=0.006). Univariate COX analysis showed that lymph node metastasis (P=0.011), distant metastasis (P=0.001) and EAR expression (P=0.010) were prognostic factors in patients with colorectal cancer. Multivariate COX regression analysis showed that distant metastasis (P=0.017) and EAR expression (P=0.036) were independent prognostic factors affecting the prognosis of patients with colorectal cancer. Conclusion Preoperative EAR can be used as a reference index for the prognosis of colon cancer patients with normal CEA and CA-199 expression.

参考文献/References:

[1]刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-14.[2]Egerer E,Siemonsen S,Erbguth F.Akute Erkrankungen von Gehirn und Herz : Wechselseitige T?覿ter-Opfer-Beziehung [Acute diseases of the brain and heart : A reciprocal culprit-victim relationship][J].Med Klin Intensivmed Notfmed,2018,113(6):456-463.[3]Siegel RL,Miller KD,Wagle NS,et al.Cancer statistics, 2023[J].CA Cancer J Clin,2023,73(1):17-48.[4]Biller LH,Schrag D.Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review[J].JAMA,2021,325(7):669-685.[5]Groux-Degroote S,Delannoy P.Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy[J].Int J Mol Sci,2021,22(11):6145.[6]Lakemeyer L,Sander S,Wittau M,et al.Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer[J].Diseases,2021,9(1):21.[7]Jain S,Maque J,Galoosian A,et al.Optimal Strategies for Colorectal Cancer Screening[J].Curr Treat Options Oncol,2022,23(4):474-493.[8]马琛茹,关泉林,郝建鹏,等.血清Hcy、CEA、CA199对结直肠癌诊断价值及其分期的相关性研究[J].西部医学,2019,31(10):1549-1553.[9]Xiang W,Lv Q,Shi H,et al.Aptamer-based biosensor for detecting carcinoembryonic antigen[J].Talanta,2020,214:120716.[10]Stiksma J,Grootendorst DC,van der Linden PW.CA 19-9 as a marker in addition to CEA to monitor colorectal cancer[J].Clin Colorectal Cancer,2014,13(4):239-244.[11]Kasi PM,Kamatham S,Shahjehan F,et al.BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer[J].J Gastrointest Oncol,2020,11(2):236-241.[12]姚宏伟,吴鸿伟,刘荫华.从传统“群体化”诊治到精准“个体化”医疗：AJCC第八版结直肠癌分期系统更新解读[J].中华外科杂志,2017,55(1):24-27.[13]Zhou J,Zheng R,Zhang S,et al.Colorectal cancer burden and trends: Comparison between China and major burden countries in the world[J].Chin J Cancer Res,2021,33(1):1-10.[14]McKeown E,Nelson DW,Johnson EK,et al.Current approaches and challenges for monitoring treatment response in colon and rectal cancer[J].J Cancer,2014,5(1):31-43.[15]Fong Y,Fortner J,Sun RL,et al.Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases[J].Ann Surg,1999,230(3):309-321.[16]徐亦君,李招胜,竺明晨.结直肠癌患者血液肿瘤标记物和粪便隐血结果的临床价值及相关性分析[J].西部医学,2023,35(7):987-991.[17]郑智琴,周海洋,施加才.围术期血清癌胚抗原、糖类抗原19-9及其比值对结直肠癌患者术后预后的临床价值[J].中国临床医生杂志,2021,49(7):773-778.[18]石方玉.Ki67、EGFR、P53及血清肿瘤标记物CEA、CA199对结直肠癌预后的价值分析[D].承德:承德医学院,2022.[19]王峰,李春梅,李南阳,等.血清AGR、CEA、CA199及MIC-1表达在老年结直肠癌诊断及预后评估中的应用价值[J].现代生物医学进展,2023,23(18):3591-3595.[20]刘海军.血清肿瘤标志物联合检测对结直肠癌患者手术预后的评估价值[J].中国卫生工程学,2023,22(4):516-518.[21]Zhang J,Cao Y,Zhang P,et al.Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma[J].Neuroendocrinology,2022,112(8):733-743. [22]于航.术前CEA、CA19-9等5种肿瘤标记物与结直肠癌病理参数及临床分期的相关性分析[D].南宁:广西医科大学,2019.[23]Wang K,Ma L,Chen L,et al.The clinical value of a nomogram constructed from CEA, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer[J].Cancer Biomark,2023,38(4):537-549.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
　ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Journal of Medical Information,2018,31(08):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]陈学敏,彭 琼.中性粒细胞与淋巴细胞比值联合癌胚抗原对结直肠癌早期诊断的研究[J].医学信息,2019,32(02):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
　CHEN Xue-min,PENG Qiong.Early Diagnosis of Colorectal Cancer by Neutrophil-lymphocyte Ratio Combined with Carcinoembryonic Antigen[J].Journal of Medical Information,2019,32(08):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
[3]李在明,魏正强.外泌体在结直肠癌中的研究进展[J].医学信息,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
　LI Zai-ming,WEI Zheng-qiang.Research Progress of Exosomes in Colorectal Cancer[J].Journal of Medical Information,2019,32(08):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
[4]周玲玲,鞠乐乐,颜 玉.结直肠癌患者手术前后血清IGF-1水平变化及临床价值分析[J].医学信息,2019,32(04):121.[doi:10.3969/j.issn.1006-1959.2019.04.039]
　ZHOU Ling-ling,JU Le-le,YAN Yu.Analysis of Changes and Clinical Value of Serum IGF-1 Levels in Patients with Colorectal Cancer before and after Operation[J].Journal of Medical Information,2019,32(08):121.[doi:10.3969/j.issn.1006-1959.2019.04.039]
[5]陈小玉,白 鍊,贺春香.结直肠癌根治手术患者营养状况调查[J].医学信息,2019,32(05):83.[doi:10.3969/j.issn.1006-1959.2019.05.025]
　CHEN Xiao-yu,BAI Lian,HE Chun-xiang.Investigation on Nutritional Status of Patients Undergoing Radical Surgery for Colorectal Cancer[J].Journal of Medical Information,2019,32(08):83.[doi:10.3969/j.issn.1006-1959.2019.05.025]
[6]李大略,赵资文,刘兆礼,等.加速康复外科对合并有糖尿病的结直肠癌患者术后炎症反应与营养代谢的影响[J].医学信息,2019,32(07):67.[doi:10.3969/j.issn.1006-1959.2019.07.021]
　LI Da-lue,ZHAO Zi-wen,LIU Zhao-li,et al.Effect of Accelerated Rehabilitation Surgery on Postoperative Inflammatory Response and Nutrient Metabolism in Patients with Colorectal Cancer Complicated with Diabetes[J].Journal of Medical Information,2019,32(08):67.[doi:10.3969/j.issn.1006-1959.2019.07.021]
[7]王逸飞,王 志,左宏波,等.伊利替康联合替吉奥在晚期结直肠癌治疗的临床研究[J].医学信息,2019,32(07):158.[doi:10.3969/j.issn.1006-1959.2019.07.049]
　WANG Yi-fei,WANG Zhi,ZUO Hong-bo,et al.Clinical Study of Irinotecan Combined with Tegafur,Gimeracil and Oteracil Porassium Capsulesin the Treatment of Advanced Colorectal Cancer[J].Journal of Medical Information,2019,32(08):158.[doi:10.3969/j.issn.1006-1959.2019.07.049]
[8]谢 勇,涂经楷,肖明盛,等.腹腔镜与传统开腹结直肠癌根治术手术效果对比[J].医学信息,2019,32(11):98.[doi:10.3969/j.issn.1006-1959.2019.11.026]
　XIE Yong,TU Jing-kai,XIAO Ming-sheng,et al.Comparative of Laparoscopic and Traditional Open Radical Rectal Cancer Radical Operation[J].Journal of Medical Information,2019,32(08):98.[doi:10.3969/j.issn.1006-1959.2019.11.026]
[9]李莎莎,李 芳,王卫峰,等.地中海饮食与结直肠癌的相关研究[J].医学信息,2019,32(15):6.[doi:10.3969/j.issn.1006-1959.2019.15.003]
　LI Sha-sha,LI Fang,WANG Wei-feng,et al.Correlation between Mediterranean Diet and Colorectal Cancer[J].Journal of Medical Information,2019,32(08):6.[doi:10.3969/j.issn.1006-1959.2019.15.003]
[10]孙 峰,鲍扬漪,朱 婷,等.晚期结直肠癌抗血管生成靶向治疗研究进展[J].医学信息,2019,32(17):1.[doi:10.3969/j.issn.1006-1959.2019.17.001]
　SUN Feng,BAO Yang-yi,ZHU Ting,et al.Advances in Anti-angiogenesis Targeted Therapy for Advanced Colorectal Cancer[J].Journal of Medical Information,2019,32(08):1.[doi:10.3969/j.issn.1006-1959.2019.17.001]

更新日期/Last Update: 1900-01-01